Showing results (221-230 of 256) with videos related to

Sort By:
Pageof 26
International Journal of Clinical Oncology|June 4, 2015
Phase II trial of an alternating regimen consisting of first-line mFOLFOX6 plus bevacizumab and FOLFIRI plus bevacizumab for patients with metastatic colorectal cancer: FIREFOX plus bevacizumab trial (KSCC0801)Keisuke Miwa, Eiji Oki, Yasunori Emi, et al.
Oncotarget|October 21, 2017
HCaRG/COMMD5 inhibits ErbB receptor-driven renal cell carcinomaHiroyuki Matsuda, Carole G Campion, Kyoko Fujiwara, et al.
Plos One|June 13, 2014
Crisis of Japanese vascular flora shown by quantifying extinction risks for 1618 taxaTaku Kadoya, Akio Takenaka, Fumiko Ishihama, et al.
Surgical Case Reports|September 29, 2020
Hepatic resection for recurrent hepatocellular carcinoma during pregnancy: a case reportTakashi Maeda, Daisuke Imai, Huanlin Wang, et al.
Investigational New Drugs|June 10, 2016
Continuation maintenance therapy with S-1 in chemotherapy-naïve patients with advanced squamous cell lung cancerSeiichiro Suzuki, Masato Karayama, Naoki Inui, et al.
Frontiers in Psychiatry|June 28, 2018
Cognitive Behavioral Therapy for Insomnia as Adjunctive Therapy to Antipsychotics in Schizophrenia: A Case ReportMuneto Izuhara, Hiroyuki Matsuda, Ami Saito, et al.
Fukuoka Igaku Zasshi = Hukuoka Acta Medica|December 25, 2013
Case of early adenosquamous carcinoma of the stomachYasue Kimura, Hiroyuki Matsuda, Hiroshi Saeki, et al.
Investigational New Drugs|February 22, 2019
Switch maintenance therapy with S-1 after induction therapy with carboplatin and nanoparticle albumin-bound paclitaxel in advanced lung squamous cell carcinomaNorimichi Akiyama, Masato Karayama, Naoki Inui, et al.
Medical Oncology (Northwood, London, England)|June 18, 2018
Switch maintenance therapy with docetaxel and bevacizumab after induction therapy with cisplatin, pemetrexed, and bevacizumab in advanced non-squamous non-small cell lung cancer: a phase II studyKoji Nishimoto, Masato Karayama, Naoki Inui, et al.
International Journal of Chronic Obstructive Pulmonary Disease|November 6, 2019
Effect of PD-1 inhibitor on exhaled nitric oxide and pulmonary function in non-small cell lung cancer patients with and without COPDYuzo Suzuki, Naoki Inui, Masato Karayama, et al.
Pageof 26